Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asunaprevir, Daclatasvir, and Beclabuvir in HCV Genotype 1 and 4
NCT01455090Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of beclabuvir in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Started Nov 2011; status: completed.
02
Drugs
beclabuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01455090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455090.